at Investor's Business Daily (Jan 20, 2015)
A pump from Johnson & Johnson (JNJ) automatically calculated and delivered the right amount of insulin to patients with Type 1 diabetes at night in a study involving 20 adults. The diabetics' blood-sugar levels were in the recommended range for over 90% of the night. The subjects were under supervision on an overnight visit to testing facilities during the study; J&J plans to conduct another of these feasibility trials before starting evaluations in which the patients use the device at home. (See Medtronics pump)
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Jan 20, 2015)
at CNBC.com (Jan 20, 2015)
Pre-Market Earnings Report for January 20, 2015 : JNJ, MS, DAL, HAL, BHI, MTB, RF, IGTE, ATI, EDU, MTG, SAPat Nasdaq.com (Jan 16, 2015)
at CNBC.com (Jan 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs